The exclusion of the PBS and other funding processes and decisions from administrative review is confounded by proposals to significantly expand the remit and power of health technology assessment advisory committees.
If the Government expands their power, they need to be made more accountable
March 25, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Wegovy pill available in Australia from today by private prescription
November 20, 2026 - - Latest News -
It happened last time, so it makes sense to start next week assuming it as the base case
November 20, 2026 - - Latest News -
Applying the principles of the Reserve Bank review to HTA advisory committees
November 20, 2026 - - Latest News -
Government turns again to cheaper medicines as Guild eyes co-payment freeze
November 19, 2026 - - Latest News -
Moderna's mRNA flu vaccines and a GLP-1 review headline March PBAC agenda
November 19, 2026 - - Latest News -
New Zealand risks losing $763 million clinical trials sector as other countries step up
November 19, 2026 - -
A tale of two government programs - one held flat and the other still running hot
November 19, 2026 - - Latest News

